#oncology
9 articles
Earnings & Corporate Events
Cardiff Oncology CEO Faces FDA Trial Endpoint Risk as Q1 Data Nears
ViaNews Editorial Team (Markets)•
Biotech Equities
Kyntra Bio faces catastrophic risk as FG-3246 oncology trial failure looms
ViaNews Editorial Team (Markets)•
Pharma Sector Trading
Pharma Giants Reshape Portfolios as Oncology Pipelines Drive Sector Optimism
ViaNews Editorial Team (Markets)•
Healthcare Sector
Pharma Giants Double Down on Oncology: Acquisitions and FDA Wins Reshape Cancer Drug Investment Landscape
ViaNews Editorial Team (Markets)•
Analysis
Four Immunotherapy Companies Race Toward 2026 Launches as Next-Generation Cancer Treatments Near Market
ViaNews Editorial Team (Markets)•
Analysis
Major Drugmakers Reshape Cancer Treatment Through Billion-Dollar Acquisitions, FDA Approvals
ViaNews Editorial Team (Markets)•
Technology
Guardant Health Reports Strong Q4 Revenue Growth Amid Market Competition
ViaNews Editorial Team (Markets)•